RankAlpha logo
Back to Rankings

KYNB

Kyntra BioD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
KYNB has two identifiable Q4 2026 pipeline milestones: the FG-3246 interim analysis and planned roxadustat Phase 3 initiation. The finalized roxadustat protocol, continued FG-3246 enrollment, supportive MATTERHORN-referenced data, and runway into 2028 provide a constructive operating backdrop.
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
FG-3246 interim data may disappoint or be delayed.
Momentum
95
Value
61
Sentiment
37
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $6.40 · Bull $10.00 · Bear $2.80Analysis 2026-08-18; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-11 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-18 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-09-11

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-11. Definitions

Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $36.00
Why
Momentum95 · Δ7d -
Value61 · Δ7d -0.0
Sentiment37 · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.

Confirming evidence

  • Sentiment remains the lead driver in the composite.

Contradictions & invalidation

  • FG-3246 interim data may disappoint or be delayed.
  • Negative Q2 revenue and the reported adjusted EPS miss may pressure sentiment.
  • The thesis remains event-driven and clinically binary.

Catalyst clock

2026-08-22

Mixed Q2 print leaves near-term sentiment fragile

Lead driver: Sentiment · See AI snapshot
Momentum
95
9% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
61
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
-0.7
Sentiment
37
62% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade

Composite grade D. Momentum 94.6 / Value 60.5 / Sentiment 36.5

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-18. Scenario method

B+
Bull case
25%
Probability
Target price
$10.00
Analysis reference price unavailable
Analysis 2026-08-18 · RankAlpha Sentiment Codex
Most likely
B
Base case
45%
Probability
Target price
$6.40
Analysis reference price unavailable
Analysis 2026-08-18 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$2.80
Analysis reference price unavailable
Analysis 2026-08-18 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$27.58M
Beta
0.84
Shares Out
4.05M
P/E (TTM)
0.2
P/S (TTM)
4.35
P/FCF (TTM) · Derived
-0.72
Rev YoY
-209.3%
EPS YoY
-257.3%
Gross Margin
+1.6%
Op Margin
-596.1%
Net Debt
-$69.42M
Current Ratio
2.69
As of 2026-09-11 • Updated nightlySource: Internal modelMethods & Data